Astrazeneca to Collaborate With Abbisko Therapeutics for Potential Non-Small Cell Lung Cancer Treatment

Summary

Astrazeneca announced a collaboration with Abbisko Therapeutics to develop a potential treatment for non-small cell lung cancer. The agreement represents a strategic partnership in oncology development.